FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3171097935> ?p ?o ?g. }

• W3171097935 endingPage "861" @default.
• W3171097935 startingPage "849" @default.
• W3171097935 abstract "There are deficient data on prevalence of germline mutations in breast cancer susceptibility genes 1 and 2 (BRCA1/BRCA2) in Indian patients with ovarian cancer who are not selected by clinical features.This prospective, cross-sectional, noninterventional study in nine Indian centers included patients with newly diagnosed or relapsed epithelial ovarian, primary peritoneal, or fallopian tube cancer. The primary objective was to assess the prevalence of BRCA1/BRCA2 mutations, and the secondary objective was to correlate BRCA1/BRCA2 status with clinicopathologic characteristics. Mutation testing was performed by a standard next-generation sequencing assay.Between March 2018 and December 2018, 239 patients with a median age of 53.0 (range, 23.0-86.0 years) years were included, of whom 203 (84.9%) had newly diagnosed disease, 36 (15.1%) had family history of ovarian or breast cancer, and 159 (66.5%) had serous subtype of epithelial ovarian cancer. Germline pathogenic or likely pathogenic mutations in BRCA1 and BRCA2 were detected in 37 (15.5%; 95% CI, 11.1 to 20.7) and 14 (5.9%; 95% CI, 3.2 to 9.6) patients, respectively, whereas variants of uncertain significance in these genes were seen in four (1.7%; 95% CI, 0.5 to 4.2) and six (2.5%; 95% CI, 0.9 to 5.4) patients, respectively. The prevalence of pathogenic or likely pathogenic BRCA mutations in patients with serous versus nonserous tumors, with versus without relevant family history, and ≤ 50 years versus > 50 years, were 40 of 159 (25.2%; 95% CI, 18.6 to 32.6) versus 11 of 80 (13.8%; 95% CI, 7.1 to 23.3; P = .0636), 20 of 36 (55.6%; 95% CI, 38.1 to 72.1) versus 41 of 203 (20.2%; 95% CI, 14.9 to 26.4; P < .0001), and 20 of 90 (22.2%; 95% CI, 14.1 to 32.2) versus 31 of 149 (20.8%; 95% CI, 14.6 to 28.2; P = .7956), respectively.There is a high prevalence of pathogenic or likely pathogenic germline BRCA mutations in Indian patients with ovarian cancer." @default.
• W3171097935 created "2021-06-22" @default.
• W3171097935 creator A5002358626 @default.
• W3171097935 creator A5007558296 @default.
• W3171097935 creator A5032206980 @default.
• W3171097935 creator A5033932153 @default.
• W3171097935 creator A5046825948 @default.
• W3171097935 creator A5051407707 @default.
• W3171097935 creator A5057512038 @default.
• W3171097935 creator A5058903725 @default.
• W3171097935 creator A5060389354 @default.
• W3171097935 creator A5067372808 @default.
• W3171097935 date "2021-12-01" @default.
• W3171097935 modified "2023-10-12" @default.
• W3171097935 title "Prevalence of <i>BRCA1</i> and <i>BRCA2</i> Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study" @default.
• W3171097935 cites W1969693388 @default.
• W3171097935 cites W1996642588 @default.
• W3171097935 cites W2001983094 @default.
• W3171097935 cites W2007111593 @default.
• W3171097935 cites W2046056066 @default.
• W3171097935 cites W2049078742 @default.
• W3171097935 cites W2079195034 @default.
• W3171097935 cites W2084985708 @default.
• W3171097935 cites W2090740451 @default.
• W3171097935 cites W2102004732 @default.
• W3171097935 cites W2110137106 @default.
• W3171097935 cites W2135525536 @default.
• W3171097935 cites W2160621493 @default.
• W3171097935 cites W2497897254 @default.
• W3171097935 cites W2529023750 @default.
• W3171097935 cites W2735861455 @default.
• W3171097935 cites W2745493620 @default.
• W3171097935 cites W2783585287 @default.
• W3171097935 cites W2791678556 @default.
• W3171097935 cites W2891920666 @default.
• W3171097935 cites W2902530726 @default.
• W3171097935 cites W2902757309 @default.
• W3171097935 cites W2914044539 @default.
• W3171097935 cites W2946015669 @default.
• W3171097935 cites W2957101013 @default.
• W3171097935 cites W3015141169 @default.
• W3171097935 cites W3023274953 @default.
• W3171097935 cites W3038757962 @default.
• W3171097935 cites W3128646645 @default.
• W3171097935 cites W4292528167 @default.
• W3171097935 cites W754073086 @default.
• W3171097935 doi "https://doi.org/10.1200/go.21.00051" @default.
• W3171097935 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8457852" @default.
• W3171097935 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34101484" @default.
• W3171097935 hasPublicationYear "2021" @default.
• W3171097935 type Work @default.
• W3171097935 sameAs 3171097935 @default.
• W3171097935 citedByCount "19" @default.
• W3171097935 countsByYear W31710979352021 @default.
• W3171097935 countsByYear W31710979352022 @default.
• W3171097935 countsByYear W31710979352023 @default.
• W3171097935 crossrefType "journal-article" @default.
• W3171097935 hasAuthorship W3171097935A5002358626 @default.
• W3171097935 hasAuthorship W3171097935A5007558296 @default.
• W3171097935 hasAuthorship W3171097935A5032206980 @default.
• W3171097935 hasAuthorship W3171097935A5033932153 @default.
• W3171097935 hasAuthorship W3171097935A5046825948 @default.
• W3171097935 hasAuthorship W3171097935A5051407707 @default.
• W3171097935 hasAuthorship W3171097935A5057512038 @default.
• W3171097935 hasAuthorship W3171097935A5058903725 @default.
• W3171097935 hasAuthorship W3171097935A5060389354 @default.
• W3171097935 hasAuthorship W3171097935A5067372808 @default.
• W3171097935 hasBestOaLocation W31710979351 @default.
• W3171097935 hasConcept C104317684 @default.
• W3171097935 hasConcept C109825262 @default.
• W3171097935 hasConcept C121608353 @default.
• W3171097935 hasConcept C126322002 @default.
• W3171097935 hasConcept C13514818 @default.
• W3171097935 hasConcept C143998085 @default.
• W3171097935 hasConcept C150173356 @default.
• W3171097935 hasConcept C2775883341 @default.
• W3171097935 hasConcept C2777249960 @default.
• W3171097935 hasConcept C2780427987 @default.
• W3171097935 hasConcept C2780673598 @default.
• W3171097935 hasConcept C2781179581 @default.
• W3171097935 hasConcept C29456083 @default.
• W3171097935 hasConcept C501734568 @default.
• W3171097935 hasConcept C530470458 @default.
• W3171097935 hasConcept C54355233 @default.
• W3171097935 hasConcept C71924100 @default.
• W3171097935 hasConcept C86803240 @default.
• W3171097935 hasConceptScore W3171097935C104317684 @default.
• W3171097935 hasConceptScore W3171097935C109825262 @default.
• W3171097935 hasConceptScore W3171097935C121608353 @default.
• W3171097935 hasConceptScore W3171097935C126322002 @default.
• W3171097935 hasConceptScore W3171097935C13514818 @default.
• W3171097935 hasConceptScore W3171097935C143998085 @default.
• W3171097935 hasConceptScore W3171097935C150173356 @default.
• W3171097935 hasConceptScore W3171097935C2775883341 @default.
• W3171097935 hasConceptScore W3171097935C2777249960 @default.
• W3171097935 hasConceptScore W3171097935C2780427987 @default.
• W3171097935 hasConceptScore W3171097935C2780673598 @default.
• W3171097935 hasConceptScore W3171097935C2781179581 @default.

• next